This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scharf, R. E. Articles by Kladetzky, R. G. Search for Related Content PubMed PubMed Citation Articles by Scharf, R. E. Articles by Kladetzky, R. G.

Stroke, Vol 13, 454-458, Copyright © 1982 by American Heart Association

ARTICLES

Cerebral ischemia in young patients: it is associated with mitral valve prolapse and abnormal platelet activity in vivo?

RE Scharf, M Hennerici, V Bluschke, J Lueck and RG Kladetzky

The etiology of cerebrovascular disease (CDV) in young patients is difficult to establish if the common causes of a focal neurological deficit are excluded by appropriate investigations. Since in some observations prolapse of the mitral-valve (MVP), alterations of platelet function, or both have been linked with cerebral ischemic events, we studied the in vivo platelet release reaction and the incidence of MVP in 47 patients (12 males, 35 females) under 45 years of age with TIA or stroke of unknown cause and in an age- and sex- matched control group. The mean plasma beta-thromboglobulin (beta-TG) level of the patients (mean = 54.9 +/- 31.4 ng/ml) was significantly higher than that of the controls (mean = 20.6 /- 6.9 ng/ml, p less than 0.001). MVP was demonstrated in 13 of 47 patients in contrast to 4 of the controls (p less than 0.01). However, the beta-T levels of patients with MVP (n = 13, 52.9 +/- 25.5 ng/ml) did not differ from those of patients without MVP (n = 34, 55.7 +/- 33.7 ng/ml) significantly (p less than 0.4). Our results confirm that the incidence of MVP is higher in young patients with cerebral ischemia of unknown cause than in asymptomatic controls. The significantly elevated plasma beta-TG concentrations in the patient's group indicate an increased platelet activity in vivo. Since there was no significant difference between beta-TG levels of patients with and without MVP, the mitral-valve abnormality can not be the cause for the altered platelet activity.

This article has been cited by other articles:

				E. Atalar, T. Aqil, K. Aytemir, I. Haznedarolu, N. Ozer, H. Kiliq, G. Kuru, S. Aksdyek, K. Ovtinq, S. Kes, et al. Diminished Global Fibrinolytic Capacity in Patients With Mitral Valve Prolapse Is Associated With Transient Ischemic Attacks Clinical and Applied Thrombosis/Hemostasis, January 1, 2002; 8(1): 41 - 44. [Abstract] [PDF]

				D. Gilon, F. S. Buonanno, M. M. Joffe, M. Leavitt, J. E. Marshall, J. P. Kistler, and R. A. Levine Lack of Evidence of an Association between Mitral-Valve Prolapse and Stroke in Young Patients N. Engl. J. Med., July 1, 1999; 341(1): 8 - 13. [Abstract] [Full Text] [PDF]

				A. J. Orencia, G. W. Petty, B. K. Khandheria, J. F. Annegers, D. J. Ballard, J. D. Sicks, W. M. O'Fallon, and J. P. Whisnant Risk of Stroke With Mitral Valve Prolapse in Population-Based Cohort Study Stroke, January 1, 1995; 26(1): 7 - 13. [Abstract] [Full Text]